HealthEquity, Inc. (NASDAQ:HQY) Position Boosted by Deutsche Bank AG

Deutsche Bank AG lifted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 25.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 118,199 shares of the company's stock after acquiring an additional 24,289 shares during the period. Deutsche Bank AG owned approximately 0.14% of HealthEquity worth $11,341,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. EP Wealth Advisors LLC boosted its holdings in shares of HealthEquity by 9.7% in the 4th quarter. EP Wealth Advisors LLC now owns 4,555 shares of the company's stock worth $437,000 after purchasing an additional 403 shares in the last quarter. Cetera Investment Advisers raised its stake in HealthEquity by 6.7% during the fourth quarter. Cetera Investment Advisers now owns 3,572 shares of the company's stock valued at $343,000 after buying an additional 225 shares during the last quarter. Brevan Howard Capital Management LP bought a new position in HealthEquity in the 4th quarter valued at approximately $200,000. Captrust Financial Advisors lifted its position in HealthEquity by 117.7% during the fourth quarter. Captrust Financial Advisors now owns 21,959 shares of the company's stock valued at $2,107,000 after purchasing an additional 11,871 shares during the period. Finally, Brown Advisory Inc. boosted its position in HealthEquity by 12.0% in the fourth quarter. Brown Advisory Inc. now owns 2,086,026 shares of the company's stock worth $200,154,000 after purchasing an additional 224,016 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the stock. The Goldman Sachs Group reduced their price target on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a report on Thursday, March 27th. Raymond James raised HealthEquity from an "outperform" rating to a "strong-buy" rating and lowered their price target for the stock from $120.00 to $115.00 in a report on Tuesday, March 25th. KeyCorp dropped their price target on HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Wells Fargo & Company upped their target price on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 26th. Finally, Barrington Research reissued an "outperform" rating and set a $112.00 target price on shares of HealthEquity in a research note on Friday, April 11th. One equities research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, HealthEquity presently has a consensus rating of "Buy" and a consensus target price of $111.75.

Insider Buying and Selling at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total value of $446,487.50. Following the transaction, the director now owns 84,969 shares in the company, valued at approximately $6,597,842.85. This trade represents a 6.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of the company's stock in a transaction on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the transaction, the executive vice president now owns 56,655 shares of the company's stock, valued at $4,433,820.30. This trade represents a 13.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is owned by corporate insiders.

HealthEquity Stock Performance

NASDAQ HQY traded down $0.63 during trading on Monday, reaching $97.60. The company's stock had a trading volume of 468,691 shares, compared to its average volume of 794,811. The firm has a market cap of $8.44 billion, a price-to-earnings ratio of 89.54, a P/E/G ratio of 1.60 and a beta of 0.45. The business's fifty day moving average price is $87.88 and its 200-day moving average price is $97.12. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.